A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Attacks in Children
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the effectiveness and safety of topiramate
compared with placebo in the prevention of migraine attacks in children (12 to 17 years of
age).
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.